Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Clinical Genitourinary Cancer
|
August 8, 2021
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
Brian A Costello, Nrupen A Bhavsar, Yousef Zakharia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Nizar M Tannir, Sabina Signoretti, Toni K Choueiri, et al.
Cancer
|
March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2016
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Toni K Choueiri, Mayer N Fishman, Bernard Escudier, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
JAMA Oncology
|
October 21, 2021
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma
Laure Hirsch, Nieves Martinez Chanza, Subrina Farah, et al.
European Urology Open Science
|
December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Karen A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Cancer
|
May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
Daniel J George, Susan Halabi, Elisabeth I Heath, et al.
American Journal of Obstetrics and Gynecology
|
October 2, 2007
A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome
Timothy M Crombleholme, David Shera, Hanmin Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2019
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020
Robert J Motzer, Eric Jonasch, M Dror Michaelson, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Clinical Genitourinary Cancer
|
August 8, 2021
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience
Brian A Costello, Nrupen A Bhavsar, Yousef Zakharia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Nizar M Tannir, Sabina Signoretti, Toni K Choueiri, et al.
Cancer
|
March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2016
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Toni K Choueiri, Mayer N Fishman, Bernard Escudier, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
JAMA Oncology
|
October 21, 2021
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma
Laure Hirsch, Nieves Martinez Chanza, Subrina Farah, et al.
European Urology Open Science
|
December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Karen A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Cancer
|
May 5, 2021
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
Daniel J George, Susan Halabi, Elisabeth I Heath, et al.
American Journal of Obstetrics and Gynecology
|
October 2, 2007
A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome
Timothy M Crombleholme, David Shera, Hanmin Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2019
NCCN Guidelines Insights: Kidney Cancer, Version 2.2020
Robert J Motzer, Eric Jonasch, M Dror Michaelson, et al.
Page
of 19